Heymann D L, Nakano J, Durand B
Med Trop (Mars). 1979 Jan-Feb;39(1):67-70.
Rimevax, a thermostabile measles vaccine, has been stored, before reconstitution, during seven days at temperature from 23 degrees C to 25 degrees C. This vaccine has given seroconversion in 87 per 100 of the babies vaccinated and aged from 9 to 24 months. This percentage assesses the value of Rimevax for field campaigns.
Rimevax是一种耐热的麻疹疫苗，在复溶前已在23摄氏度至25摄氏度的温度下储存了七天。每100名年龄在9至24个月的接种该疫苗的婴儿中，有87名出现了血清转化。这一百分比评估了Rimevax在现场接种活动中的价值。
